Nature 595, 114–119 (2021)
Severe COVID-19 cases are often accompanied by complex host responses that involve diverse cell types. Using a powerful single-nucleus RNA sequencing approach, Izar and colleagues focus on cellular changes in the lungs of 19 patients who died of COVID-19.
The authors identified myeloid cells as the dominant source of dysregulated inflammation in COVID-19 and found evidence of impaired T cell responses. Compromised lung regeneration could be traced back to a failure of alveolar type 2 (AT2) cells to transition into AT1 cells, as observed during normal repair. Instead, AT2 cells persisted in a transient, intermediate progenitor state previously described in fibrotic lung injury.
Further analysis pinpointed the cellular sources of inflammatory cytokines, such as IL-1β, IL-6 and interferons that contributed to the hyperinflammatory environment and probably also the transient state. The authors concluded that myeloid-derived IL-1β might be one of the distinguishing factors in COVID-19 pathology, separating it from other viral or bacterial infections. Increased numbers of pulmonary-fibrosis-promoting fibroblasts were also described.
The atlas describes SARS-CoV-2 lung pathology at a single-cell level and provides an important resource for the evaluation of disease complications and therapeutic options.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weber, C. COVID-19 lung atlas. Nat Cell Biol 23, 1108 (2021). https://doi.org/10.1038/s41556-021-00779-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41556-021-00779-7